MRPL44 and differentiated thyroid carcinoma: MRPL44 expression was identified as a predictor of lymph node metastasis in papillary thyroid carcinoma [39], and MRPL13 inhibition was shown to be a key upstream regulator of OXPHOS dysfunction and hepatoma cell invasiveness [40].